Cholesterol pill tested as shield against liver cancer
Prevention
Recruiting now
This study is testing whether a low dose of the cholesterol-lowering drug atorvastatin (Lipitor) can reduce the risk of developing liver cancer in people who have advanced liver scarring (fibrosis or cirrhosis). About 60 adults with this high-risk condition will take either the s…
Phase: PHASE2 • Sponsor: Raymond Chung • Aim: Prevention
Last updated Mar 30, 2026 14:28 UTC